How should BMD testing be used to monitor the response to osteoporosis therapy?
BMD testing to monitor osteoporosis therapy responses is most often repeated after 2 years of treatment. To accurately interpret serial changes, the LSC for the specific instrument must be known. The LSC is a precision estimate that informs the user about the minimum BMD change that should be considered significant. Standard procedures for performing the LSC assessment are available on the International Society for Clinical Densitometry website, www.iscd.org .